This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Metastasis-Free Survival

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Metastasis-Free Survival Means

Metastasis-Free Survival, often called MFS, is the length of time after cancer treatment during which a patient is still alive and the cancer has not spread to other parts of the body. Metastasis means cancer cells have moved from the original tumor to distant organs or tissues. MFS tracks how long a person remains free from this spread after starting treatment.

This measure is different from other survival terms. For example, disease-free survival means no cancer can be detected at all after treatment, while progression-free survival means the cancer is present but not growing. MFS specifically focuses on the time before distant spread occurs.

Why Metastasis-Free Survival Matters

MFS is important because the spread of cancer to other parts of the body often changes treatment options and outlook. By knowing how long a patient remains metastasis-free, doctors can better understand how well a treatment is working to control the disease. It is commonly used in clinical trials to compare new treatments and in clinical care to monitor patients over time.

While MFS gives useful information about cancer control, it is one of several survival measures doctors consider. It helps guide decisions about follow-up care and additional treatments.

Where Patients Might Encounter This Term

Patients may hear about MFS during discussions of test results, treatment plans, or clinical trial information. It might appear in medical reports or research studies describing how long patients lived without cancer spreading. Sometimes it is listed as MFS or distant metastasis–free survival (DMFS).

Understanding this term can help patients and caregivers ask informed questions about prognosis and treatment effectiveness.

What Metastasis-Free Survival Does Not Automatically Mean

It is important to know that MFS is a statistical measure based on groups of patients, not a prediction for any one person. A longer MFS in a study does not guarantee the same outcome for every individual. Also, MFS does not tell the whole story about overall survival or quality of life.

Patients should avoid assuming that MFS alone defines their prognosis or treatment success without discussing the full clinical context with their care team.

How to Use This Information

If you see MFS mentioned in your medical records or reports, ask your doctor what it means for your specific situation. Questions like “How does my metastasis-free survival compare to others with my cancer type?” or “What does this mean for my treatment plan?” can help you understand your care better.

Remember that survival terms are tools to help guide care and research, not definitive predictions. Always discuss any concerns or questions with your healthcare provider.

Educational Purpose and Next Steps

This explanation is meant to help you understand the term Metastasis-Free Survival in cancer care. It does not replace medical advice or decisions tailored to your personal health. If you encounter this term in your care, the best next step is to talk with your healthcare team about what it means for you and your treatment options.

Sources

Public source information used for this glossary entry includes: